Intellia Therapeutics (NTLA) Q4 2025 Earnings

Nov 6Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.33
-1.19
-1.06
-0.92

Details

Expected EPS
-1.005235
Actual EPS
-0.92
Surprise EPS
0.09
Surprise Percent
+8.48%

Description

⁨Intellia Therapeutics⁩ (⁦NTLA⁩) has reported earnings of ⁦-0.92⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts